Literature DB >> 6349399

Trypanosoma cruzi: antigenic analysis of cloned stocks.

V Bongertz, J A Dvorak.   

Abstract

The antigenic constitution of two Trypanosoma cruzi strains and six cloned stocks was determined immunoelectrophoretically. Five to seven antigens common to all of the T. cruzi stocks were found. However, each stock also contained "strain-specific antigens," and five of the six cloned stocks presented "clone-specific antigens." These data demonstrate that a T. cruzi strain is composed of an antigenically heterogeneous population of organisms.

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6349399     DOI： 10.4269/ajtmh.1983.32.716

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN： 0002-9637            Impact factor:   2.345


  5 in total

1.  Trypanosoma cruzi: properties of a clone isolated from CL strain.

Authors:  M T Lima; A M Jansen; E Rondinelli; C R Gattass
Journal:  Parasitol Res       Date:  1991       Impact factor: 2.289

2.  Identification and partial characterization of Trypanosoma cruzi antigens recognized by T cells and immune sera from patients with Chagas' disease.

Authors:  R T Gazzinelli; V M Leme; J R Cancado; G Gazzinelli; J Scharfstein
Journal:  Infect Immun       Date:  1990-05       Impact factor: 3.441

3.  Antigenic analysis of Trypanosoma cruzi strains by crossed immunoelectrophoresis: demonstration and isolation of antigens particular to some strains.

Authors:  M G Morgado; M Van Hoegaerden; B Galvão-Castro
Journal:  Z Parasitenkd       Date:  1985

4.  Serodiagnosis of American trypanosomosis by using nonpathogenic trypanosomatid antigen.

Authors:  V M Monteón; L Guzmán-Rojas; C Negrete-García; J L Rosales-Encina; P A Lopez
Journal:  J Clin Microbiol       Date:  1997-12       Impact factor: 5.948

5.  The major 85-kD surface antigen of the mammalian form of Trypanosoma cruzi is encoded by a large heterogeneous family of simultaneously expressed genes.

Authors:  S Kahn; W C Van Voorhis; H Eisen
Journal:  J Exp Med       Date:  1990-08-01       Impact factor: 14.307
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.